Diagnostic pitfalls in patients referred for arrhythmogenic right ventricular cardiomyopathy

被引:4
|
作者
Sampognaro, James R. [1 ]
Gaine, Sean P. [1 ]
Sharma, Apurva [1 ]
Tichnell, Crystal [1 ]
Murray, Brittney [1 ]
Shaik, Zeba [1 ]
Zimmerman, Stefan L. [1 ]
James, Cynthia A. [1 ]
Gasperetti, Alessio [1 ]
Calkins, Hugh [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, 600 N Wolfe St, Baltimore, MD 21287 USA
关键词
Arrhythmogenic right ventricular cardiomyopathy; Cardiac magnetic resonance imaging; Implantable cardioverter-defibrillator; Misdiagnosis; Task Force Criteria; CARDIAC SARCOIDOSIS; FOLLOW-UP; DYSPLASIA/CARDIOMYOPATHY; GENETICS; IMPACT;
D O I
10.1016/j.hrthm.2023.08.035
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND The diagnosis of arrhythmogenic right ventricular cardiomyopathy (ARVC) is challenging because of nonspecific clinical findings and lack of conclusive answers from genetic testing (ie, an ARVC-related variant is neither necessary nor sufficient for diagnosis). Despite the revised 2010 Task Force Criteria, patients are still misdiagnosed with ARVC. OBJECTIVE In patients referred for ARVC, we sought to identify the clinical characteristics and diagnostic confounders for those patients in whom ARVC was ultimately ruled out. METHODS Patients who were referred to our center with previously diagnosed or suspected ARVC (between January 2011 and September 2019; N = 726) were included in this analysis. RESULTS Among 726 patients, ARVC was ruled out in 365 (50.3%). The most common presenting symptoms in ruled-out patients were palpitations (n = 139, 38.1%), ventricular arrhythmias (n = 62, 17.0%), and chest pain (n = 53, 14.5%). On the basis of outside evaluation, 23.8% of these patients had received implantable cardioverter-defibrillators (ICDs) and device extraction was recommended in 9.0% after reevaluation. An additional 5.5% had received ICD recommendations, all of which were reversed on reevaluation. The most frequent final diagnoses were idiopathic premature ventricular contractions/ventricular tachycardia/ventricular fibrillation (46.6%), absence of disease (19.2%), and noncardiac presyncope/syncope (17.5%). The most common contributor to diagnostic error was cardiac magnetic resonance imaging, including mistaken right ventricular wall motion abnormalities (33.2%) and nonspecific fat (12.1%). CONCLUSION False suspicion or misdiagnosis was found in the majority of patients referred for ARVC, resulting in inappropriate ICD implantation or recommendation in 14.5% of these patients. Misdiagnosis or false suspicion was most commonly due to misinterpretation of cardiac magnetic resonance imaging.
引用
收藏
页码:1720 / 1726
页数:7
相关论文
共 50 条
  • [41] Intracardiac Thrombosis in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy
    Wu, Lingmin
    Yao, Yan
    Chen, Gang
    Fan, Xiaohan
    Zheng, Lihui
    Ding, Ligang
    Zhang, Shu
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2014, 25 (12) : 1359 - 1362
  • [42] Right ventricular longitudinal contractility mismatch: a novel diagnostic marker of right ventricular arrhythmogenic cardiomyopathy
    Bocchino, P. P.
    Frea, S.
    Angelini, F.
    Gravinese, C.
    Gallone, G.
    Clivio, A.
    Toso, E.
    Giustetto, C.
    De Ferrari, G. M.
    EUROPEAN HEART JOURNAL, 2022, 43 : 10 - 10
  • [43] Supraventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy
    Weber, A.
    Muessigbrodt, A.
    Heindl, M.
    Ebert, M.
    Dinov, B.
    Richter, S.
    Doering, M.
    Hindricks, G.
    Arya, A.
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 : S300 - S300
  • [44] Arrhythmogenic right ventricular cardiomyopathy: From genetics to diagnostic and therapeutic challenges
    Pinamonti, Bruno
    Brun, Francesca
    Mestroni, Luisa
    Sinagra, Gianfranco
    WORLD JOURNAL OF CARDIOLOGY, 2014, 6 (12): : 1234 - 1244
  • [45] Arrhythmogenic right ventricular dysplasia/cardiomyopathy: In search of a diagnostic electrocardiographic marker
    Bhargava, Kartikeya
    HEART RHYTHM, 2008, 5 (10) : 1422 - 1423
  • [46] Plakoglobin: A diagnostic marker of arrhythmogenic right ventricular cardiomyopathy in forensic pathology?
    Julie Munkholm
    Claus B. Andersen
    Gyda L. Ottesen
    Forensic Science, Medicine, and Pathology, 2015, 11 : 47 - 52
  • [47] Exome sequencing in arrhythmogenic right ventricular cardiomyopathy: a new diagnostic tool?
    Gandjbakhch, Estelle
    Villard, Eric
    EUROPACE, 2017, 19 (06): : 889 - 890
  • [48] Development of a molecular genetic diagnostic service for arrhythmogenic right ventricular cardiomyopathy
    Reid, Sarah
    Thomson, K.
    Blair, E.
    Seller, A.
    JOURNAL OF MEDICAL GENETICS, 2008, 45 : S79 - S79
  • [49] Usefulness of Immunostaining for Plakoglobin as a Diagnostic Marker of Arrhythmogenic Right Ventricular Cardiomyopathy
    Munkholm, Julie
    Christensen, Alex H.
    Svendsen, Jesper H.
    Andersen, Claus B.
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 109 (02): : 272 - 275
  • [50] Plakoglobin: A diagnostic marker of arrhythmogenic right ventricular cardiomyopathy in forensic pathology?
    Munkholm, Julie
    Andersen, Claus B.
    Ottesen, Gyda L.
    FORENSIC SCIENCE MEDICINE AND PATHOLOGY, 2015, 11 (01) : 47 - 52